Citations (83)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Paul Chan, Li Shao, Brian Tomlinson, Yuzhen Zhang & Zhong-Min Liu. (2019) An evaluation of pitavastatin for the treatment of hypercholesterolemia. Expert Opinion on Pharmacotherapy 20:1, pages 103-113.
Read now
Read now
Mireia Campos-Martorell, Mary Cano-Sarabia, Alba Simats, Mar Hernández-Guillamon, Anna Rosell, Daniel Maspoch & Joan Montaner. (2016) Charge effect of a liposomal delivery system encapsulating simvastatin to treat experimental ischemic stroke in rats. International Journal of Nanomedicine 11, pages 3035-3048.
Read now
Read now
Fen Chen, Xuejia Zhai, Chaoran Zhu & Yongning Lu. (2015) Effects of capsaicin on pharmacokinetics of pitavastatin in rats. Xenobiotica 45:2, pages 171-176.
Read now
Read now
Miao Hu, Valiant WL Mak, Yajie Xiao & Brian Tomlinson. (2013) Associations Between the Genotypes and Phenotype of CYP3A and the Lipid Response to Simvastatin in Chinese Patients with Hypercholesterolemia. Pharmacogenomics 14:1, pages 25-34.
Read now
Read now
Katherine S. Fenner, Hannah M. Jones, Mohammed Ullah, Sarah Kempshall, Maurice Dickins, Yurong Lai, Paul Morgan & Hugh A. Barton. (2012) The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: from obscure liver transporters to key determinants of hepatobiliary clearance. Xenobiotica 42:1, pages 28-45.
Read now
Read now
Alberto Corsini & Richard Ceska. (2011) Drug–drug interactions with statins: will pitavastatin overcome the statins’ Achilles’ heel?. Current Medical Research and Opinion 27:8, pages 1551-1562.
Read now
Read now
E. Bergman, M. Hedeland, U. Bondesson & H. Lennernäs. (2010) The effect of acute administration of rifampicin and imatinib on the enterohepatic transport of rosuvastatin in vivo. Xenobiotica 40:8, pages 558-568.
Read now
Read now
Tamio Teramoto, Hitoshi Shimano, Koutaro Yokote & Mitsuyoshi Urashima. (2010) New evidence on pitavastatin: efficacy and safety in clinical studies. Expert Opinion on Pharmacotherapy 11:5, pages 817-828.
Read now
Read now
Yasushi Saito. (2009) Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals. Vascular Health and Risk Management 5, pages 921-936.
Read now
Read now
Y. Uno, T. Kumano, G. Kito, R. Nagata, T. Kamataki & H. Fujino. (2007) CYP2C76-mediated species difference in drug metabolism: A comparison of pitavastatin metabolism between monkeys and humans. Xenobiotica 37:1, pages 30-43.
Read now
Read now
Articles from other publishers (73)
Carlos Cruz-Cortés, M. Andrés Velasco-Saavedra, Eli Fernández-de Gortari, Guadalupe Guerrero-Serna, Rodrigo Aguayo-Ortiz & L. Michel Espinoza-Fonseca. (2023) A novel machine learning-based screening identifies statins as inhibitors of the calcium pump SERCA. Journal of Biological Chemistry 299:5, pages 104681.
Crossref
Crossref
Donata Pluskota-Karwatka & Marcin Hoffmann. (2023) Computational studies on statins photoactivity. Physical Sciences Reviews 8:2, pages 239-258.
Crossref
Crossref
Luna Prieto Garcia, Anna Lundahl, Christine Ahlström, Anna Vildhede, Hans Lennernäs & Erik Sjögren. (2022) Does the choice of applied physiologically‐based pharmacokinetics platform matter? A case study on simvastatin disposition and drug–drug interaction. CPT: Pharmacometrics & Systems Pharmacology 11:9, pages 1194-1209.
Crossref
Crossref
Sijia Liu, Jiawei Lin, Rui Ding & Xiangping Nie. (2022) Simvastatin as an emerging pollutant on non-target aquatic invertebrates: effects on antioxidant-related genes in Daphnia magna. Environmental Science and Pollution Research 29:34, pages 52248-52262.
Crossref
Crossref
Weiwei Zeng, Miao Hu, Hon Kit Lee, Elaine Wat, Clara Bik San Lau, Chung Shun Ho, Chun Kwok Wong & Brian Tomlinson. (2022) Effects of Soy Isoflavones and Green Tea Extract on Simvastatin Pharmacokinetics and Influence of the SLCO1B1 521T > C Polymorphism. Frontiers in Nutrition 9.
Crossref
Crossref
Naomi T. Jessurun, Marjolein Drent, Petal A. Wijnen, Ankie M. Harmsze, Eugène P. van Puijenbroek, Otto Bekers & Aalt Bast. (2021) Role of Drug–Gene Interactions and Pharmacogenetics in Simvastatin-Associated Pulmonary Toxicity. Drug Safety 44:11, pages 1179-1191.
Crossref
Crossref
Anne M. Filppula, Päivi Hirvensalo, Heli Parviainen, Vilma E. Ivaska, K. Ivar Lönnberg, Feng Deng, Jenni Viinamäki, Mika Kurkela, Mikko Neuvonen & Mikko Niemi. (2021) Comparative Hepatic and Intestinal Metabolism and Pharmacodynamics of Statins. Drug Metabolism and Disposition 49:8, pages 658-667.
Crossref
Crossref
Javier Reig-López, Alfredo García-Arieta, Víctor Mangas-Sanjuán & Matilde Merino-Sanjuán. (2021) Current Evidence, Challenges, and Opportunities of Physiologically Based Pharmacokinetic Models of Atorvastatin for Decision Making. Pharmaceutics 13:5, pages 709.
Crossref
Crossref
Lucy Darakjian, Malavika Deodhar, Jacques Turgeon & Veronique Michaud. (2021) Chronic Inflammatory Status Observed in Patients with Type 2 Diabetes Induces Modulation of Cytochrome P450 Expression and Activity. International Journal of Molecular Sciences 22:9, pages 4967.
Crossref
Crossref
Ayaka Shiozawa, Satoshi Yamaori, Shinobu Kamijo & Shigeru Ohmori. (2021) Effects of acid and lactone forms of statins on S-warfarin 7-hydroxylation catalyzed by human liver microsomes and recombinant CYP2C9 variants (CYP2C9.1 and CYP2C9.3). Drug Metabolism and Pharmacokinetics 36, pages 100364.
Crossref
Crossref
Christine M. Bowman, Fang Ma, Jialin Mao & Yuan Chen. (2020) Examination of Physiologically‐Based Pharmacokinetic Models of Rosuvastatin. CPT: Pharmacometrics & Systems Pharmacology 10:1, pages 5-17.
Crossref
Crossref
Kenichi Umehara, Carina Cantrill, Matthias Beat Wittwer, Elisa Di Lenarda, Florian Klammers, Aynur Ekiciler, Neil Parrott, Stephen Fowler & Mohammed Ullah. (2020) Application of the Extended Clearance Classification System (ECCS) in Drug Discovery and Development: Selection of Appropriate In Vitro Tools and Clearance Prediction. Drug Metabolism and Disposition 48:10, pages 849-860.
Crossref
Crossref
Yiting Yang, Ping Li, Zexin Zhang, Zhongjian Wang, Li Liu & Xiaodong Liu. (2020) Prediction of Cyclosporin-Mediated Drug Interaction Using Physiologically Based Pharmacokinetic Model Characterizing Interplay of Drug Transporters and Enzymes. International Journal of Molecular Sciences 21:19, pages 7023.
Crossref
Crossref
Cristina Ruiz-Iruela, Beatriz Candás-Estébanez, Xavier Pintó-Sala, Neus Baena-Díez, Assumpta Caixàs-Pedragós, Roser Güell-Miró, Rosa Navarro-Badal, Pilar Calmarza, Jose Luis Puzo-Foncilla, Pedro Alía-Ramos & Ariadna Padró-Miquel. (2019) Genetic contribution to lipid target achievement with statin therapy: a prospective study. The Pharmacogenomics Journal 20:3, pages 494-504.
Crossref
Crossref
Hayrettin Ozan Gulcan, Serkan Yigitkan & Ilkay Erdogan Orhan. (2019) The Natural Products as Hydroxymethylglutaryl-Coa Reductase Inhibitors. Letters in Drug Design & Discovery 16:10, pages 1130-1137.
Crossref
Crossref
Ying Li, Yin Wu, Ya-Jing Li, Lu Meng, Cong-Yang Ding & Zhan-Jun Dong. (2019) Effects of Silymarin on the In Vivo Pharmacokinetics of Simvastatin and Its Active Metabolite in Rats. Molecules 24:9, pages 1666.
Crossref
Crossref
Halina Falfushynska, Eugene P. Sokolov, Fouzia Haider, Christina Oppermann, Udo Kragl, Wolfgang Ruth, Marius Stock, Sabrina Glufke, Eileen J. Winkel & Inna M. Sokolova. (2019) Effects of a common pharmaceutical, atorvastatin, on energy metabolism and detoxification mechanisms of a marine bivalve Mytilus edulis. Aquatic Toxicology 208, pages 47-61.
Crossref
Crossref
William D. KlarenIvan Rusyn. (2018) High-Content Assay Multiplexing for Muscle Toxicity Screening in Human-Induced Pluripotent Stem Cell-Derived Skeletal Myoblasts. ASSAY and Drug Development Technologies 16:6, pages 333-342.
Crossref
Crossref
Shuang Bao, Xiangping Nie, Yang Liu, Chao Wang & Sijia Liu. (2018) Response of PXR signaling pathway to simvastatin exposure in mosquitofish (Gambusia affinis) and its histological changes. Ecotoxicology and Environmental Safety 154, pages 228-236.
Crossref
Crossref
Angela Pirillo & Alberico L. Catapano. (2017) Pitavastatin and HDL: Effects on plasma levels and function(s). Atherosclerosis Supplements 27, pages e1-e9.
Crossref
Crossref
Jonathan Wagner & Susan M. Abdel-Rahman. (2016) Pediatric Statin Administration: Navigating a Frontier with Limited Data. The Journal of Pediatric Pharmacology and Therapeutics 21:5, pages 380-403.
Crossref
Crossref
Negar Maghsoodi & Anthony S. Wierzbicki. (2016) Statin myopathy. Current Opinion in Cardiology 31:4, pages 417-425.
Crossref
Crossref
Ju-E Liu, Bin Ren, Lan Tang, Qian-Jie Tang, Xiao-Ying Liu, Xin Li, Xue Bai, Wan-Ping Zhong, Jin-Xiu Meng, Hao-Ming Lin, Hong Wu, Ji-Yan Chen & Shi-Long Zhong. (2016) The independent contribution of miRNAs to the missing heritability in CYP3A4/5 functionality and the metabolism of atorvastatin. Scientific Reports 6:1.
Crossref
Crossref
Janne T. Backman, Anne M. Filppula, Mikko Niemi & Pertti J. Neuvonen. (2015) Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions. Pharmacological Reviews 68:1, pages 168-241.
Crossref
Crossref
Hee Youn Choi, Kyun-Seop Bae, Sang-Heon Cho, Jong-Lyul Ghim, Sangmin Choe, Jin Ah Jung, Seok-Joon Jin, Hee-Sun Kim & Hyeong-Seok Lim. (2015) Impact of CYP2D6, CYP3A5, CYP2C19, CYP2A6, SLCO1B1, ABCB1, and ABCG2 gene polymorphisms on the pharmacokinetics of simvastatin and simvastatin acid. Pharmacogenetics and Genomics 25:12, pages 595-608.
Crossref
Crossref
Yücel Başpınar, Evren Gündoğdu, Çinel Köksal & Ercüment Karasulu. (2015) Pitavastatin-containing nanoemulsions: Preparation, characterization and in vitro cytotoxicity. Journal of Drug Delivery Science and Technology 29, pages 117-124.
Crossref
Crossref
Annett Kunze, Birk Poller, Jörg Huwyler & Gian Camenisch. (2015) Application of the extended clearance concept classification system (ECCCS) to predict the victim drug-drug interaction potential of statins. Drug Metabolism and Personalized Therapy 30:3, pages 175-188.
Crossref
Crossref
Mostafa A. Borahay, Kathleen Vincent, Massoud Motamedi, Elena Sbrana, Gokhan S. Kilic, Ayman Al-Hendy & Darren Boehning. (2015) Novel effects of simvastatin on uterine fibroid tumors: in vitro and patient-derived xenograft mouse model study. American Journal of Obstetrics and Gynecology 213:2, pages 196.e1-196.e8.
Crossref
Crossref
T Eley, Y‐H Han, S‐P Huang, B He, W Li, W Bedford, M Stonier, D Gardiner, K Sims, AD Rodrigues & RJ Bertz. (2014) Organic Anion Transporting Polypeptide‐Mediated Transport of, and Inhibition by, Asunaprevir, an Inhibitor of Hepatitis C Virus NS3 Protease. Clinical Pharmacology & Therapeutics 97:2, pages 159-166.
Crossref
Crossref
Swagatika Sahoo, Hulda S. Haraldsdóttir, Ronan M. T. Fleming & Ines Thiele. (2014) Modeling the effects of commonly used drugs on human metabolism. The FEBS Journal 282:2, pages 297-317.
Crossref
Crossref
Katarzyna Chruszcz‐Lipska, Aleksandra Jaworska, Ewelina Szczurek & Malgorzata Baranska. (2014) (−)‐R‐Mevalonolactone Studied by ROA and SERS Spectroscopy. Chirality 26:9, pages 453-461.
Crossref
Crossref
Sony Tuteja, Danielle Duffy, Richard L. Dunbar, Rajesh Movva, Ram Gadi, LeAnne T. Bloedon & Marina Cuchel. (2013) Pharmacokinetic Interactions of the Microsomal Triglyceride Transfer Protein Inhibitor, Lomitapide, with Drugs Commonly Used in the Management of Hypercholesterolemia. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34:3, pages 227-239.
Crossref
Crossref
Hilary J. Bews, Jules C. Carlson, Aruni Jha, Sujata Basu, Andrew J. Halayko & Charles S. Wong. (2014) Simultaneous quantification of simvastatin and simvastatin hydroxy acid in blood serum at physiological pH by ultrahigh performance liquid chromatography–tandem mass spectrometry (UHPLC/MS/MS). Journal of Chromatography B 947-948, pages 145-150.
Crossref
Crossref
Francesco Pelliccia, Giuseppe Rosano, Giuseppe Marazzi, Cristiana Vitale, Ilaria Spoletini, Ferdinando Franzoni, Giuseppe Speziale, Marina Polacco, Cesare Greco & Carlo Gaudio. (2014) Pharmacodynamic Comparison of Pitavastatin Versus Atorvastatin on Platelet Reactivity in Patients With Coronary Artery Disease Treated With Dual Antiplatelet Therapy. Circulation Journal 78:3, pages 679-684.
Crossref
Crossref
Luis Masana. (2013) Pitavastatin in cardiometabolic disease: therapeutic profile. Cardiovascular Diabetology 12:Suppl 1, pages S2.
Crossref
Crossref
Jonathan Wagner & J. Steven Leeder. (2012) Pediatric Pharmacogenomics. Pediatric Clinics of North America 59:5, pages 1017-1037.
Crossref
Crossref
Roger E. Morgan, Stuart E. Campbell, Kazuhito Suehira, Craig A. Sponseller, Christine Y. Yu & Matthew M. Medlock. (2012) Effects of Steady-State Lopinavir/Ritonavir on the Pharmacokinetics of Pitavastatin in Healthy Adult Volunteers. JAIDS Journal of Acquired Immune Deficiency Syndromes 60:2, pages 158-164.
Crossref
Crossref
Ophelia Qi Ping Yin, Valiant Wah Lun Mak, Miao Hu, Benny Siu Pong Fok, Moses Sing Sum Chow & Brian Tomlinson. (2012) Impact of CYP2D6 polymorphisms on the pharmacokinetics of lovastatin in Chinese subjects. European Journal of Clinical Pharmacology 68:6, pages 943-949.
Crossref
Crossref
Xing Liu, Albert DeJesus, Zhisong Cao, Dana Vardeman & Beppino Giovanella. (2012) Metabolic Difference of CZ48 in Human and Mouse Liver Microsomes. International Journal of Molecular Sciences 13:5, pages 5498-5505.
Crossref
Crossref
J S Floyd, R Kaspera, K D Marciante, N S Weiss, S R Heckbert, T Lumley, K L Wiggins, B Tamraz, P-Y Kwok, R A Totah & B M Psaty. (2012) A Screening Study of Drug–Drug Interactions in Cerivastatin Users: An Adverse Effect of Clopidogrel. Clinical Pharmacology & Therapeutics 91:5, pages 896-904.
Crossref
Crossref
Yutaro Suzuki, Mami Saito & Toshiyuki Someya. (2012) Delirium associated with duloxetine in a depressed patient with Alzheimer's dementia. Psychiatry and Clinical Neurosciences 66:2, pages 166-166.
Crossref
Crossref
Linnea M. Baudhuin. 2012. Pharmacogenomics in Clinical Therapeutics. Pharmacogenomics in Clinical Therapeutics
98
126
.
Joachim Bucher, Stephan Riedmaier, Anke Schnabel, Katrin Marcus, Gabriele Vacun, Thomas S Weiss, Wolfgang E Thasler, Andreas K Nüssler, Ulrich M Zanger & Matthias Reuss. (2011) A systems biology approach to dynamic modeling and inter-subject variability of statin pharmacokinetics in human hepatocytes. BMC Systems Biology 5:1.
Crossref
Crossref
Yasushi Saito. (2011) Pitavastatin: An overview. Atherosclerosis Supplements 12:3, pages 271-276.
Crossref
Crossref
Kathrin Sabine Ellesat, Mazyar Yazdani, Tor Fredrik Holth & Ketil Hylland. (2011) Species-dependent sensitivity to contaminants: An approach using primary hepatocyte cultures with three marine fish species. Marine Environmental Research 72:4, pages 216-224.
Crossref
Crossref
Laurie L. Yee & Eric A. Wright. (2011) Pitavastatin Calcium: Clinical Review of a New Antihyperlipidemic Medication. Clinical Therapeutics 33:8, pages 1023-1042.
Crossref
Crossref
Yasushi Saito. (2011) Treatment Options for Hypercholesterolemia and Combined Dyslipidemia: Focus on Pitavastatin. Clinical Medicine Insights: Therapeutics 3, pages CMT.S6565.
Crossref
Crossref
Simran D.S. Maggo, Martin A. Kennedy & David W.J. Clark. (2011) Clinical Implications of Pharmacogenetic Variation on the Effects of Statins. Drug Safety 34:1, pages 1-19.
Crossref
Crossref
Tochi Okwuosa. 2011. Hyperlipidemia in Primary Care. Hyperlipidemia in Primary Care
181
204
.
Alberico L. Catapano. (2010) Pitavastatin – pharmacological profile from early phase studies. Atherosclerosis Supplements 11:3, pages 3-7.
Crossref
Crossref
Joyce H. S. You, Winnie K. Y. Chan, Polly F. P. Chung, Miao Hu & Brian Tomlinson. (2013) Effects of Concomitant Therapy with Diltiazem on the Lipid Responses to Simvastatin in Chinese Subjects. The Journal of Clinical Pharmacology 50:10, pages 1151-1158.
Crossref
Crossref
Rüdiger Kaspera, Suresh B. Naraharisetti, Bani Tamraz, Tariku Sahele, Matthew J. Cheesman, Pui-Yan Kwok, Kristin Marciante, Susan R. Heckbert, Bruce M. Psaty & Rheem A. Totah. (2010) Cerivastatin in vitro metabolism by CYP2C8 variants found in patients experiencing rhabdomyolysis. Pharmacogenetics and Genomics 20:10, pages 619-629.
Crossref
Crossref
Ebba Bergman, Elin M. Matsson, Mikael Hedeland, Ulf Bondesson, Lars Knutson & Hans Lennernäs. (2013) Effect of a Single Gemfibrozil Dose on the Pharmacokinetics of Rosuvastatin in Bile and Plasma in Healthy Volunteers. The Journal of Clinical Pharmacology 50:9, pages 1039-1049.
Crossref
Crossref
Kathrin Sabine Ellesat, Knut-Erik Tollefsen, Anders Åsberg, Kevin V. Thomas & Ketil Hylland. (2010) Cytotoxicity of atorvastatin and simvastatin on primary rainbow trout (Oncorhynchus mykiss) hepatocytes. Toxicology in Vitro 24:6, pages 1610-1618.
Crossref
Crossref
Kristian M. BaileySimon P.R. RomaineBeryl M. JacksonAmanda J. FarrinMaria EfthymiouJulian H. BarthJoanne CopelandTerry McCormackAndrew WhiteheadMarcus D. FlatherNilesh J. SamaniJane NixonAlistair S. HallAnthony J. Balmforth. (2010) Hepatic Metabolism and Transporter Gene Variants Enhance Response to Rosuvastatin in Patients With Acute Myocardial Infarction. Circulation: Cardiovascular Genetics 3:3, pages 276-285.
Crossref
Crossref
Karl J. OttmarLisa M. ColosiJames A. Smith. (2010) Sorption of Statin Pharmaceuticals to Wastewater-Treatment Biosolids, Terrestrial Soils, and Freshwater Sediment. Journal of Environmental Engineering 136:3, pages 256-264.
Crossref
Crossref
Hideki Fujino, Tsuyoshi Saito, Shin-ichiro Ogawa & Junji Kojima. (2005) Transporter-mediated influx and efflux mechanisms of pitavastatin, a new inhibitor of HMG-CoA reductase. Journal of Pharmacy and Pharmacology 57:10, pages 1305-1311.
Crossref
Crossref
S Riedmaier, K Klein, U Hofmann, J E Keskitalo, P J Neuvonen, M Schwab, M Niemi & U M Zanger. (2009) UDP-Glucuronosyltransferase (UGT) Polymorphisms Affect Atorvastatin Lactonization In Vitro and In Vivo. Clinical Pharmacology & Therapeutics 87:1, pages 65-73.
Crossref
Crossref
Ebba Bergman, Anna Lundahl, Patrik Fridblom, Mikael Hedeland, Ulf Bondesson, Lars Knutson & Hans Lennernäs. (2009) Enterohepatic Disposition of Rosuvastatin in Pigs and the Impact of Concomitant Dosing with Cyclosporine and Gemfibrozil. Drug Metabolism and Disposition 37:12, pages 2349-2358.
Crossref
Crossref
Daisuke Yamasaki, Tsutomu Nakamura, Noboru Okamura, Makiko Kokudai, Naoki Inui, Kazuhiko Takeuchi, Hiroshi Watanabe, Midori Hirai, Katsuhiko Okumura & Toshiyuki Sakaeda. (2009) Effects of acid and lactone forms of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on the induction of MDR1 expression and function in LS180 cells. European Journal of Pharmaceutical Sciences 37:2, pages 126-132.
Crossref
Crossref
Shosaku Nomura. (2009) Pitavastatin in the Management of Hypercholesterolemia. Clinical Medicine. Therapeutics 1, pages CMT.S2690.
Crossref
Crossref
Satoshi Kitamura, Kazuya Maeda, Yi Wang & Yuichi Sugiyama. (2008) Involvement of Multiple Transporters in the Hepatobiliary Transport of Rosuvastatin. Drug Metabolism and Disposition 36:10, pages 2014-2023.
Crossref
Crossref
Marcin Hoffmann & Marcin Nowosielski. (2008) DFT study on hydroxy acid–lactone interconversion of statins: the case of atorvastatin. Organic & Biomolecular Chemistry 6:19, pages 3527.
Crossref
Crossref
I Ieiri, S Suwannakul, K Maeda, H Uchimaru, K Hashimoto, M Kimura, H Fujino, M Hirano, H Kusuhara, S Irie, S Higuchi & Y Sugiyama. (2007) SLCO1B1 (OATP1B1, an Uptake Transporter) and ABCG2 (BCRP, an Efflux Transporter) Variant Alleles and Pharmacokinetics of Pitavastatin in Healthy Volunteers. Clinical Pharmacology & Therapeutics 82:5, pages 541-547.
Crossref
Crossref
Bernard Testa & Stefanie D. Krämer. (2007) The Biochemistry of Drug Metabolism – An Introduction. Chemistry & Biodiversity 4:9, pages 2031-2122.
Crossref
Crossref
Giulia Caron, Giuseppe Ermondi & Bernard Testa. (2007) Predicting the Oxidative Metabolism of Statins: An Application of the MetaSite® Algorithm. Pharmaceutical Research 24:3, pages 480-501.
Crossref
Crossref
Ebba Bergman, Patrik Forsell, Annica Tevell, Eva M. Persson, Mikael Hedeland, Ulf Bondesson, Lars Knutson & Hans Lennernäs. (2006) Biliary secretion of rosuvastatin and bile acids in humans during the absorption phase. European Journal of Pharmaceutical Sciences 29:3-4, pages 205-214.
Crossref
Crossref
Yoshihisa Shitara & Yuichi Sugiyama. (2006) Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: Drug–drug interactions and interindividual differences in transporter and metabolic enzyme functions. Pharmacology & Therapeutics 112:1, pages 71-105.
Crossref
Crossref
E.A. SCONCE, T.I. KHAN, A.K. DALY, H.A. WYNNE & F. KAMALI. (2006) The impact of simvastatin on warfarin disposition and dose requirements. Journal of Thrombosis and Haemostasis 4:6, pages 1422-1424.
Crossref
Crossref
Yoshihisa Shitara, Toshiharu Horie & Yuichi Sugiyama. (2006) Transporters as a determinant of drug clearance and tissue distribution. European Journal of Pharmaceutical Sciences 27:5, pages 425-446.
Crossref
Crossref
Toshiyuki Sakaeda, Hideki Fujino, Chiho Komoto, Mikio Kakumoto, Jiang-shu Jin, Koichi Iwaki, Kohshi Nishiguchi, Tsutomu Nakamura, Noboru Okamura & Katsuhiko Okumura. (2006) Effects of Acid and Lactone Forms of Eight HMG-CoA Reductase Inhibitors on CYP-Mediated Metabolism and MDR1-Mediated Transport. Pharmaceutical Research 23:3, pages 506-512.
Crossref
Crossref
Md. Khalid Pasha, Syed Muzeeb, Shaik Jafar Sadik Basha, Dhanya Shashikumar, Ramesh Mullangi & Nuggehally R. Srinivas. (2005)
Analysis of five HMG‐CoA reductase inhibitors— atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and
in vitro
metabolism studies
. Biomedical Chromatography 20:3, pages 282-293.
Crossref
Crossref
Tomasz Grabarkiewicz, Pawel Grobelny, Marcin Hoffmann & Jadwiga Mielcarek. (2006) DFT study on hydroxy acid–lactone interconversion of statins: the case of fluvastatin. Org. Biomol. Chem. 4:23, pages 4299-4306.
Crossref
Crossref